Medicine for treating fatty liver, hepatitis and liver cirrhosis
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of fatty liver, medicine, applied in the field of medicine
Pending Publication Date: 2016-06-29
程潜
View PDF3 Cites 6 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
The interferon that is often used now has a certain curative effect on chronic hepatitis B, hepatitis C, and hepatitis cirrhosis. For example, its stable response rate for the treatment of hepatitis C is only 15%-20% (the curative effect of interferon for the treatment of hepatitis C Research: Journal of Integrative Chinese and Western Hepatology: 2002-12, Issue 1, Page 56); however, the side effects are large, the recurrence rate is high, and the price is expensive, which is not suitable for the medical consumption level of our country
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0029] Embodiment 1 A kind of medicine for the treatment of fatty liver, hepatitis, liver cirrhosis
[0030] The drug is marine algae glycoprotein;
[0031] Said marine algae glycoprotein, in parts by weight, includes sugar 1%, protein 99%,
[0052] The protein includes: asparagine, cysteine, lysine, arginine, serine, threonine, glutamic acid.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Property
Measurement
Unit
molecular weight
aaaaa
aaaaa
molecular weight
aaaaa
aaaaa
molecular weight
aaaaa
aaaaa
Login to view more
Abstract
The invention provides a medicine for treating fatty liver, hepatitis and liver cirrhosis. The medicine is a mixture of glycoprotein or polysaccharide and protein, or is polypeptide or protein. After the medicine is adopted for treatment for 3 months, the content of ALT is reduced to 41.5-45.9 IU / L, the content of TbiL is reduced to 37.3-42.6 mu mol / L, the content of Alb is reduced to 32.6-35.0 g / L, the content of HBV-DNA is reduced to 4.0-4.9 copies / mL, the sputum negative conversion rate of HbeAg is 75-82%, and the sputum negative conversion rate of HBV-DNA is 83-87%. The medicine is suitable for treating fatty liver, alcoholic liver, alcoholism, hepatic fibrosis, viral hepatitis, hepatalgia, abdominal distension, cancer and cirrhosis, has the characteristics of being safe and efficient, and being free of side effects, and has the functions of absorbing and metabolizing alcohol in the body, and eliminating alcoholism.
Description
technical field [0001] The invention relates to a medicine for treating fatty liver, hepatitis and liver cirrhosis, belonging to the technical field of medicine. Background technique [0002] The infection rate of hepatitis B virus in my country is about 60%-70%; the carrier rate of hepatitis B surface antigen accounts for about 7.18% of the total population. Based on this calculation, there are about 93 million people in the country who carry hepatitis B virus, of which about 30 million are hepatitis B patients. At present, there are many people suffering from jaundice A, hepatitis B disease, virus, and hepatitis B virus. Many reasons can cause or induce jaundice A, hepatitis B virus, and hepatitis B virus disease, such as excessive drinking, poor body resistance, poor immunity, Irregular diet, etc. For patients with liver disease, they are discriminated against to varying degrees in terms of family, marriage, school enrollment, employment, going abroad, and social interact...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more